首页 | 本学科首页   官方微博 | 高级检索  
     


Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised,phase 3 trial
Authors:Michael Friedlander  Kathleen N Moore  Nicoletta Colombo  Giovanni Scambia  Byoung-Gie Kim  Ana Oaknin  Alla Lisyanskaya  Gabe S Sonke  Charlie Gourley  Susana Banerjee  Amit Oza  Antonio González-Martín  Carol Aghajanian  William H Bradley  Joyce Liu  Cara Mathews  Frédéric Selle  Alain Lortholary  Paul DiSilvestro
Affiliation:1. University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, NSW, Australia;2. Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA;3. University of Milan-Bicocca, Milan, Italy;4. Istituto Europeo di Oncologia IRCCS, Milan, Italy;5. Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica, Rome, Italy;6. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;7. Vall d''Hebron University Hospital, Vall d''Hebron Institute of Oncology (VHIO), Barcelona, Spain;8. St Petersburg City Oncology Dispensary, St Petersburg, Russia;9. The Netherlands Cancer Institute, Amsterdam, The Netherlands;10. Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK;11. The Royal Marsden NHS Foundation Trust, London, UK;12. Institute of Cancer Research, London, UK;13. Princess Margaret Cancer Centre, Toronto, ON, Canada;14. Clínica Universidad de Navarra, Madrid, Spain;15. Memorial Sloan Kettering Cancer Center, New York, NY, USA;p. Froedtert and the Medical College of Wisconsin, Milwaukee, WI, USA;q. Dana-Farber Cancer Institute, Boston, MA, USA;r. Women and Infants Hospital, Providence, RI, USA;s. Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France;t. Groupe d''Investigateurs Nationaux pour l''Etude des Cancers Ovariens (GINECO), Paris, France;u. Centre Catherine de Sienne Hopital privé du Confluent, Nantes, France;v. AstraZeneca, Gaithersburg, MD, USA;w. AstraZeneca, Cambridge, UK;x. PAREXEL, London, UK
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号